Immune thrombocytopenia - Tissue - Live Donors

Also known as: ITP

Essential information

Obligatory

Must not donate if:

Associated with malignancy.

Discretionary

If underlying cause of thrombocytopenia or treatment given is not a contraindication, accept. Refer to relevant entry. Refer to Designated Clinical Support Officer if further advice required.

Supporting information

See if relevant

• Malignancy

If treated with immunoglobulin:

• Immunoglobulin therapy
• Transfusion

If treated with plasma exchange:

• Transfusion

If treated with immunosuppressive therapy:

• Immunosuppression

Additional information

Immune thrombocytopenia can be associated with malignancies, especially haematological malignancies such as chronic lymphocytic leukaemia.

Reason for change:

Amend the ‘Obligatory’ section, add ‘Discretionary’ and ‘Additional Information’ sections, add link to ‘immunoglobulin therapy’ and ‘malignancy’ entries.

Version details:

TL-DSG Edition 203 Release 44 (04 August 2021)